{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:21:20Z","timestamp":1791328880560,"version":"4.3.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T00:00:00Z","timestamp":1494288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/13\/5\/30177"],"award-info":[{"award-number":["RE\/13\/5\/30177"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RG\/13\/7\/30099"],"award-info":[{"award-number":["RG\/13\/7\/30099"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["CH\/12\/429762"],"award-info":[{"award-number":["CH\/12\/429762"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.lfs.2017.05.002","type":"journal-article","created":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T18:46:35Z","timestamp":1493837195000},"page":"110-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Vascular dysfunction and fibrosis in stroke-prone spontaneously hypertensive rats: The aldosterone-mineralocorticoid receptor-Nox1 axis"],"prefix":"10.1016","volume":"179","author":[{"given":"Adam P.","family":"Harvey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto C.","family":"Montezano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie Y.","family":"Hood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rheure A.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziela","family":"Ceravolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delyth","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhian M.","family":"Touyz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2017.05.002_bb0005","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.116.303697","article-title":"Inflammation, immunity, and hypertensive end-organ damage","volume":"116","author":"McMaster","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2017.05.002_bb0010","first-page":"659","article-title":"Vascular fibrosis in aging and hypertension: molecular mechanisms and clinical implications","volume":"32","author":"Harvey","year":"2016","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.lfs.2017.05.002_bb0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0895-7061(01)02291-9","article-title":"Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1","volume":"15","author":"Park","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.lfs.2017.05.002_bb0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","article-title":"Galectin-3 mediates aldosterone-induced vascular fibrosis","volume":"33","author":"Calvier","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2017.05.002_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2017.05.002_bb0030","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s00424-014-1616-x","article-title":"Role of smooth muscle cell mineralocorticoid receptor in vascular tone","volume":"467","author":"Tarjus","year":"2015","journal-title":"Pfl\u00fcgers Archiv."},{"key":"10.1016\/j.lfs.2017.05.002_bb0035","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/MNH.0000000000000153","article-title":"Redox signaling, Nox5 and vascular remodeling in hypertension","volume":"24","author":"Montezano","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.lfs.2017.05.002_bb0040","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1161\/HYPERTENSIONAHA.115.06280","article-title":"Evidence of the importance of Nox4 in production of hypertension in dahl salt-sensitive rats","volume":"67","author":"Cowley","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2017.05.002_bb0045","first-page":"288","article-title":"Molecular mechanisms of hypertension\u2014reactive oxygen species and antioxidants: a basic science update for the clinician","volume":"28","author":"Montezano","year":"2012","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.lfs.2017.05.002_bb0050","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.112.132159","article-title":"NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis","volume":"127","author":"Gray","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2017.05.002_bb0055","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1161\/CIRCRESAHA.112.267054","article-title":"Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase","volume":"110","author":"Schroder","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2017.05.002_bb0060","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/ATVBAHA.110.219238","article-title":"Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo","volume":"31","author":"Ray","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2017.05.002_bb0065","doi-asserted-by":"crossref","first-page":"C422","DOI":"10.1152\/ajpcell.00381.2008","article-title":"Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells","volume":"296","author":"Basuroy","year":"2009","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"10.1016\/j.lfs.2017.05.002_bb0070","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.107.103192","article-title":"Renal redox-sensitive signaling, but not blood pressure, is attenuated by Nox1 knockout in angiotensin II-dependent chronic hypertension","volume":"51","author":"Yogi","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2017.05.002_bb0075","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1507\/endocrj.K10E-383","article-title":"Activation of Src-ATF1 pathway is involved in upregulation of Nox1, a catalytic subunit of NADPH oxidase, by aldosterone","volume":"58","author":"Shi","year":"2011","journal-title":"Endocr. J."},{"key":"10.1016\/j.lfs.2017.05.002_bb0080","first-page":"304","article-title":"Protein kinase C-\u03b4 is involved in induction of NOX1 gene expression by aldosterone in rat vascular smooth muscle cells","volume":"75","author":"Wei","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.lfs.2017.05.002_bb0085","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2478\/s11658-011-0002-3","article-title":"The mitochondria mediate the induction of NOX1 gene expression by aldosterone in an ATF-1-dependent manner","volume":"16","author":"Fu","year":"2011","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.lfs.2017.05.002_bb0090","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1291\/hypres.29.813","article-title":"Increased expression of gp91phox homologues of NAD (P) H oxidase in the aortic media during chronic hypertension: involvement of the renin-angiotensin system","volume":"29","author":"Akasaki","year":"2006","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.lfs.2017.05.002_bb0095","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1161\/01.HYP.0000128031.31572.a3","article-title":"Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats","volume":"43","author":"Endemann","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2017.05.002_bb0100","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2017.05.002_bb0105","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/HYPERTENSIONAHA.115.06163","article-title":"Downregulation of nuclear factor erythroid 2-related factor and associated antioxidant genes contributes to redox-sensitive vascular dysfunction in hypertension","volume":"66","author":"Lopes","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2017.05.002_bb0110","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1161\/HYPERTENSIONAHA.111.180158","article-title":"Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats","volume":"59","author":"Rehman","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2017.05.002_bb0115","doi-asserted-by":"crossref","first-page":"H1081","DOI":"10.1152\/ajpheart.00752.2005","article-title":"Sex-specific differences in cerebral arterial myogenic tone in hypertensive and normotensive rats","volume":"290","author":"Ibrahim","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.lfs.2017.05.002_bb0120","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1097\/HJH.0000000000000300","article-title":"Introgressed chromosome 2 quantitative trait loci restores aldosterone regulation and reduces response to salt in the stroke-prone spontaneously hypertensive rat","volume":"32","author":"Sampson","year":"2014","journal-title":"J. Hypertens."},{"key":"10.1016\/j.lfs.2017.05.002_bb0125","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ajh.2011.20","article-title":"Effects of spironolactone on cerebral vessel structure in rats with sustained hypertension","volume":"24","author":"Rigsby","year":"2011","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.lfs.2017.05.002_bb0130","first-page":"253","article-title":"Evolving role of galectin-3 as a cardiac biomarker: heart failure with preserved ejection fraction and renal function, important pieces of the puzzle","volume":"3","author":"Christenson","year":"2015","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.lfs.2017.05.002_bb0135","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2017.05.002_bb0140","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/HYPERTENSIONAHA.115.05876","article-title":"Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension","volume":"66","author":"Mart\u00ednez-Mart\u00ednez","year":"2015","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.lfs.2017.05.002_bb0145","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/jim-2015-000014","article-title":"The relation among aldosterone, galectin-3, and myocardial fibrosis: a prospective clinical pilot follow-up study","volume":"64","author":"Liao","year":"2016","journal-title":"J. Investig. Med."},{"issue":"5","key":"10.1016\/j.lfs.2017.05.002_bb0150","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/hr.2009.26","article-title":"The expression of matrix metalloproteinase-13 is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model","volume":"32","author":"Ueno","year":"2009","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.lfs.2017.05.002_bb0155","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/46311","article-title":"The p66shc adaptor protein controls oxidative stress response and life span in mammals","volume":"402","author":"Migliaccio","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2017.05.002_bb0160","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1161\/01.CIR.0000147731.24444.4D","article-title":"Deletion of p66shc gene protects against age-related endothelial dysfunction","volume":"110","author":"Francia","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2017.05.002_bb0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.abb.2009.03.007","article-title":"Age-related changes in levels of p66Shc and serine 36-phosphorylated p66Shc in organs and mouse tissues","volume":"486","author":"Lebiedzinska","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.lfs.2017.05.002_bb0170","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.freeradbiomed.2012.03.015","article-title":"Mitochondrial dysfunction accounts for aldosterone-induced epithelial-to-mesenchymal transition of renal proximal tubular epithelial cells","volume":"53","author":"Yuan","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2017.05.002_bb0175","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1172\/JCI10506","article-title":"Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice","volume":"106","author":"Matoba","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2017.05.002_bb0180","first-page":"L393","article-title":"Hydrogen peroxide-induced pulmonary vasodilation: role of guanosine 3\u2032,5\u2032-cyclic monophosphate","volume":"261","author":"Burke-Wolin","year":"1991","journal-title":"Am. J. Phys."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517302072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517302072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:56:27Z","timestamp":1778633787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320517302072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":36,"alternative-id":["S0024320517302072"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2017.05.002","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vascular dysfunction and fibrosis in stroke-prone spontaneously hypertensive rats: The aldosterone-mineralocorticoid receptor-Nox1 axis","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2017.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}